Project Grant HT94252510614
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $165K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The U.S. Defense Health Agency awarded a $771,627 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the "TUNE AND STRIKE TARGETING OF GLIOBLASTOMA" research project. The grant, provided under the agency's Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The project, scheduled...
- This $1,644,309 Project Grant was awarded on February 1, 2025 by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420), to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will focus on functional molecular networks...
- The Defense Health Agency awarded a $783,023 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC" over a 3-year period from June 1, 2025 to May 31, 2028. The Military Medical Research and Development program supports advanced...
- This $1,460,695 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" at The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. over the period of September 1, 2025 to August 31, 2028. The project aims to transform healthcare for military service members, veterans, and...
- This federal Project Grant award, valued at $1,155,518.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct in vivo neuroepigenetics research in combat veterans with repeated blast exposure. The award, with a performance period from September 1, 2025 to August 31, 2028, will support advanced biomedical research to transform...
- This Project Grant from the Defense Health Agency provides $734,781 to Formation Venture Engineering Foundry Inc. for precision medicine immunotherapy research under the Military Medical Research and Development program (CFDA 12.420). The research aims to develop medical solutions for treating neurodegeneration in amyotrophic lateral sclerosis patients who test positive for human endogenous retrovirus K. The awardee will conduct applied and advanced biomedical research from June 2023 through...
- This Project Grant award of $240,897.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Duke University to conduct integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award, with a performance period from August 1, 2025 to July 31, 2027, will enable Duke University's Office of Research Administration to carry out this advanced biomedical research focused...
- This Project Grant award of $1,594,419.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by The Regents of the University of California, San Francisco (UCSF) on "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The research aims to develop innovative diagnostic and treatment approaches for a specific type of brain cancer through advanced biomedical investigations. This...
- This federal Project Grant award of $158,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a genetically engineered mouse model of spinal ependymoma precursors in NF2-related schwannomatosis. The project will be conducted by the Trustees of Indiana University, a prominent public research university, over a performance period from September 15, 2025 to August 14, 2027. The award aims to advance biomedical research...